GM05389
Fibroblast from Lung, Lung
Description:
APPARENTLY HEALTHY FETAL TISSUE
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Apparently Healthy Collection |
|
Biopsy Source
|
Lung
|
|
Cell Type
|
Fibroblast
|
|
Tissue Type
|
Lung
|
|
Transformant
|
Untransformed
|
|
Sample Source
|
Fibroblast from Lung, Lung
|
|
Race
|
White
|
|
Family Member
|
2
|
|
Relation to Proband
|
twin
|
|
Confirmation
|
Clinical summary/Case history
|
|
ISCN
|
46,XY
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| Passage Frozen |
1 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Chromosome Analysis |
| |
| Remarks |
Lung biopsy; 13.5 cm crown-rump length |
| Gotoh E, Visualizing Active Replication Regions in S-Phase Chromosomes Methods in molecular biology (Clifton, NJ)2519:117-126 2022 |
| PubMed ID: 36066717 |
| |
| Kucich U, Rosenbloom JC, Abrams WR, Rosenbloom J, Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. Am J Respir Cell Mol Biol26(2):183-8 2002 |
| PubMed ID: 11804868 |
| |
| Kucich U, Rosenbloom JC, Abrams WR, Bashir MM, Rosenbloom J, Stabilization of elastin mRNA by TGF-beta: initial characterization of signaling pathway [see comments] Am J Respir Cell Mol Biol17:10-6 1997 |
| PubMed ID: 9224204 |
| |
| Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ, Rettig WJ, Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci U S A91:5657-61 1994 |
| PubMed ID: 7911242 |
| Passage Frozen |
1 |
| Split Ratio |
1:5 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|